PharmaLive

1 month ago | pharmalive.com | Maria Fontanazza

Novo Nordisk’s CagriSema shows nearly 16 percent weight lossToday, Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE program. REDEFINE 2 is a 68-week efficacy and safety trial investigating once-weekly subcutaneous CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to placebo. The trial included 1,206 randomized people with obesity or overweight and type 2 diabetes and a mean baseline body weight of 102 kg.

1 month ago | pharmalive.com

Medical and biopharma industries are driving ever-accelerating advancements in genomics, technology, and AI that are improving health and medical outcomes. As a result, demands on medical marketing agencies to best serve the companies that are fueling biopharma advances depend on increased resources. Marketing growth requires technology, operational efficiency, M&A opportunities, and access to new clients. This is happening at the same time there is an overall industry decline in marketing budgets, with total spend in healthcare marketing going down by eight percent according to one leading industry resource. Biopharma agencies are increasingly turning to partnership with a private equity firm as a solution. This article addresses the benefits of PE collaboration with medical marketing agencies and how such partnerships are helping to scale for the common good.

2 months ago | pharmalive.com | Maria Fontanazza

Fingerpaint Group unifies brand, launches Fingerpaint MedicalAfter experiencing what Founder Ed Mitzen calls explosive growth over the past five years, Fingerpaint Group is bringing its solutions together under one brand. It’s a move that executives agree is a natural evolution for the company. With this announcement also comes the launch of Fingerpaint Medical (comprising MedThink Communications, MedThink SciCom, and Fingerpaint Medical Communications).

2 months ago | pharmalive.com | Maria Fontanazza

36th Annual Manny Awards: Meet the 2025 MedAdvocate JuryWith experience that spans across the pharmaceutical and life sciences industry, to health and wellness, and CPG, entertainment, and large consumer brands, this year’s panel of MedAdvocates are bringing a wealth of expertise to the 2025 Manny Awards. The unbiased panel will report to the Manny Award judging table during the finalist voting session, which will be held on Thursday, March 6 in New York City.

2 months ago | pharmalive.com | Maria Fontanazza

Women shouldn’t have to ‘suck it up’ – health should be a corporate priorityBy Maria Fontanazza • [email protected]Women live 25 percent more of their lives in poor health compared to men, according to the World Economic Forum (WEF) and the McKinsey Health Institute. A study published in Natural Communications found that on average, women are diagnosed four years later than men across 770 diseases.